[HTML][HTML] Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis

T Kishi, T Ikuta, K Sakuma, M Okuya, M Hatano… - Molecular …, 2023 - nature.com
A systematic review and random-effects model network meta-analysis were conducted to
compare the efficacy, acceptability, tolerability, and safety of antidepressants to treat adults …

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

GS Malhi, D Bassett, P Boyce… - Australian & New …, 2015 - journals.sagepub.com
Objectives: To provide guidance for the management of mood disorders, based on scientific
evidence supplemented by expert clinical consensus and formulate recommendations to …

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

N Gukasyan, AK Davis, FS Barrett… - Journal of …, 2022 - journals.sagepub.com
Background: Preliminary data suggest that psilocybin-assisted treatment produces
substantial and rapid antidepressant effects in patients with major depressive disorder …

[HTML][HTML] Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis

M Kato, H Hori, T Inoue, J Iga, M Iwata, T Inagaki… - Molecular …, 2021 - nature.com
A significant clinical issue encountered after a successful acute major depressive disorder
(MDD) treatment is the relapse of depressive symptoms. Although continuing maintenance …

Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response

PW Andrews, A Bharwani, KR Lee, M Fox… - Neuroscience & …, 2015 - Elsevier
The role of serotonin in depression and antidepressant treatment remains unresolved
despite decades of research. In this paper, we make three major claims. First, serotonin …

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines

A Cleare, CM Pariante, AH Young… - Journal of …, 2015 - journals.sagepub.com
A revision of the 2008 British Association for Psychopharmacology evidence-based
guidelines for treating depressive disorders with antidepressants was undertaken in order to …

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines

IM Anderson, IN Ferrier, RC Baldwin… - Journal of …, 2008 - journals.sagepub.com
A revision of the 2000 British Association for Psychopharmacology evidence-based
guidelines for treating depressive disorders with antidepressants was undertaken to …

[图书][B] Clinical interviewing: 2012-2013 update

J Sommers-Flanagan, R Sommers-Flanagan - 2012 - books.google.com
" It is a delight to see the Fourth Edition of Sommers-Flanagans's excellent work. They
understand counseling and therapy, their writing is clear, and this book will be enjoyed by …

A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method.

A Fekadu, S Wooderson, C Donaldson… - Journal of Clinical …, 2009 - psychiatrist.com
Objective: Treatment resistance is a common clinical phenomenon in depression. However,
current unitary models of staging fail to represent its complexity. We aimed to devise a model …

A detailed examination of cytokine abnormalities in Major Depressive Disorder

NM Simon, K McNamara, CW Chow, RS Maser… - European …, 2008 - Elsevier
Recent technological advances offer an opportunity to further elucidate the complex cytokine
network in Major Depressive Disorder (MDD). Twenty cytokines were simultaneously …